[go: up one dir, main page]

NO20050995L - Composition containing an androgenic 11β-halogen steroid and a progestational hormone as well as male contraceptive based on this composition - Google Patents

Composition containing an androgenic 11β-halogen steroid and a progestational hormone as well as male contraceptive based on this composition

Info

Publication number
NO20050995L
NO20050995L NO20050995A NO20050995A NO20050995L NO 20050995 L NO20050995 L NO 20050995L NO 20050995 A NO20050995 A NO 20050995A NO 20050995 A NO20050995 A NO 20050995A NO 20050995 L NO20050995 L NO 20050995L
Authority
NO
Norway
Prior art keywords
composition
androgenic
well
composition containing
male contraceptive
Prior art date
Application number
NO20050995A
Other languages
Norwegian (no)
Inventor
Rolf Bohlmann
Ursula-Friederike Habenicht
Reinhard Nubbermeyer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2003/008192 external-priority patent/WO2004011008A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20050995L publication Critical patent/NO20050995L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen omhandler et nytt kjemisk preparat inneholdende et androgent 11ß-halogensteroid og et progestasjonelt hormon med formel (I) , et farmasøytisk preparat inneholdende dette kjemiske preparatet og et mannlig prevensjonsmiddel basert på dette farmasøytiske preparatet.The invention relates to a novel chemical composition containing an androgenic 11β-halogen steroid and a progestational hormone of formula (I), a pharmaceutical composition containing this chemical composition and a male contraceptive based on this pharmaceutical composition.

NO20050995A 2002-07-25 2005-02-24 Composition containing an androgenic 11β-halogen steroid and a progestational hormone as well as male contraceptive based on this composition NO20050995L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10234525A DE10234525A1 (en) 2002-07-25 2002-07-25 New compositions, useful as male contraceptives, comprise synergistic active agent combination of androgenic 11beta-halo-steroid and gestagenic 14 alpha, 17alpha-ethylene-estratrienone derivative
PCT/EP2003/008192 WO2004011008A1 (en) 2002-07-25 2003-07-25 COMPOSITION CONTAINING AN ANDROGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION

Publications (1)

Publication Number Publication Date
NO20050995L true NO20050995L (en) 2005-04-25

Family

ID=30010499

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050995A NO20050995L (en) 2002-07-25 2005-02-24 Composition containing an androgenic 11β-halogen steroid and a progestational hormone as well as male contraceptive based on this composition

Country Status (9)

Country Link
AR (1) AR040691A1 (en)
CO (1) CO5690601A2 (en)
DE (1) DE10234525A1 (en)
EA (1) EA007601B1 (en)
ME (1) MEP38208A (en)
NO (1) NO20050995L (en)
RS (1) RS50907B (en)
UA (1) UA78834C2 (en)
ZA (1) ZA200501653B (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714965A1 (en) * 1987-04-30 1988-11-10 Schering Ag 3-METHYLENE-4-ANDROSTEN-17-ONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE19650352A1 (en) * 1996-12-04 1998-07-30 Jenapharm Gmbh New male oral contraceptive composition
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
DE19848303A1 (en) * 1998-10-14 2000-04-20 Schering Ag Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception
ATE355844T1 (en) * 2000-02-15 2007-03-15 Schering Ag COMPOSITION FOR MALE CONTRACEPTION, CONTAINING NORETHISTERONE AND TESTOSTERONE UNDECANOATE
EP1216699A1 (en) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermal system comprising a highly potent progestin
DE10104327A1 (en) * 2001-01-24 2002-07-25 Schering Ag New 11beta-halo-testosterone derivatives useful in male hormone replacement therapy and in male fertility control

Also Published As

Publication number Publication date
EA200500222A1 (en) 2005-08-25
RS20050049A (en) 2007-09-21
UA78834C2 (en) 2007-04-25
ZA200501653B (en) 2007-11-28
MEP38208A (en) 2011-02-10
CO5690601A2 (en) 2006-10-31
EA007601B1 (en) 2006-12-29
DE10234525A1 (en) 2004-02-05
AR040691A1 (en) 2005-04-13
RS50907B (en) 2010-08-31

Similar Documents

Publication Publication Date Title
PL374317A1 (en) Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition
BR0309819A (en) Pharmaceutical Formulations
NO20045527L (en) Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea
NO20050917L (en) Thiomolybdate analogues and applications thereof
DK1090029T3 (en) 14,15-Cyclopropane steroids from the 19-norandrostan series, process for their preparation, and pharmaceutical preparations containing these compounds
NO20065784L (en) Steroidal compounds and their use
MY141879A (en) Selective estrogen receptor modulators
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
MY138479A (en) 7alpha-hydroxyacetyl and 7alpha-hydroperoxyacetyl-substituted steroid compounds
IL145645A0 (en) N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
GB0202635D0 (en) Formulation containing novel anti-inflammatory androstane derivative
NO20050995L (en) Composition containing an androgenic 11β-halogen steroid and a progestational hormone as well as male contraceptive based on this composition
TW200503731A (en) Method of treatment
BR9713176A (en) Amorphous benzothiophenes, methods of preparation and methods of use
ATE377020T1 (en) CRYSTALLINE GAMMA-LACTONE DER17BETA-HYDROXY-
DK1635843T3 (en) Therapy that includes dienogest for hormone replacement and depression
PT1196428E (en) STEROIDS SUBSTITUTED WITH 11 BETA-ARIL-17, 17-ESPYORTIOLANE
UA91988C2 (en) Pharmaceutical compositions based on nk2 antagonists for pediatric use
AU2002339199A1 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
TR199801520A1 (en) Crystalline progestagens.
DK1235850T3 (en) Unsaturated 14,15-cyclopropano-androstanes, processes for their preparation and pharmaceutical compositions containing these compounds
TW200603812A (en) D-homo-17-chlor-16(17)-ene steroids
WO2003040316A3 (en) Selective elimination of cd52+ cells and uses thereof
姚晶晶 et al. My Happiest Day
ITFI20030238A1 (en) UROTENSIN ANTAGONIST CYCLIC PEPTIDES-II

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application